Johnson & Johnson JNJ
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $94.2B | +6% | FY ending Dec 28, 2025 |
|---|---|---|---|
| Gross profit | $63.9B | +4% | FY ending Dec 28, 2025 |
| Operating income | $21.6B | +32% | FY ending Dec 28, 2014 |
| Net income | $26.8B | +91% | FY ending Dec 28, 2025 |
| Earnings per share | $11.03 | +91% | FY ending Dec 28, 2025 |
| Research & development | $109.0M | -94% | FY ending Dec 28, 2025 |
| Cash from operations | $24.5B | +1% | FY ending Dec 28, 2025 |
| Capital spending | $4.8B | +9% | FY ending Dec 28, 2025 |
| Share buybacks | $6.0B | +145% | FY ending Dec 28, 2025 |
| Cash | $19.7B | -18% | FY ending Dec 28, 2025 |
| Long-term debt | $39.4B | +29% | FY ending Dec 28, 2025 |
| Shareholders' equity | $81.5B | +14% | FY ending Dec 28, 2025 |
Insider trades
Last 12 months: 1 open-market buy ($258K) and 22 sales ($151.3M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Timothy SchmidEVP, WW Chair, MedTech | Sold2 fills | 33,597 | $274.74 avg | $9.2M | Sep 2, 2026 |
| Jennifer L TaubertEVP, WWC. Innovative Medicine | Sold | 15,000 | $263.36 | $4.0M | Aug 17, 2026 |
| Joaquin DuatoCEO and Chairman of the Board, Director | Sold2 fills | 123,291 | $261.17 avg | $32.2M | Aug 13, 2026 |
| Elizabeth ForminardEVP, Chief Legal Officer | Sold2 fills | 15,918 | $257.00 avg | $4.1M | Aug 6, 2026 |
| Joaquin DuatoCEO and Chairman of the Board, Director | Sold2 fills | 48,480 | $258.15 avg | $12.5M | Aug 5, 2026 |
| Vanessa BroadhurstEVP, Global Corp Affairs | Sold | 23,054 | $251.27 | $5.8M | Jul 20, 2026 |
| Kathryn E WengelEVP, Chief TO and Risk Officer | Sold | 10,000 | $241.15 | $2.4M | Jun 11, 2026 |
| Robert J DeckerVP Corporate Controller | Sold | 4,075 | $247.87 | $1.0M | Feb 27, 2026 |
| Timothy SchmidEVP, WW Chair, MedTech | Sold | 1,322 | $245.66 | $325K | Feb 20, 2026 |
| Timothy SchmidEVP, WW Chair, MedTech | Sold2 fills | 22,623 | $244.33 avg | $5.5M | Feb 18, 2026 |
| Joseph J WolkExec VP, CFO | Sold4 fills | 89,654 | $242.80 avg | $21.8M | Feb 17, 2026 |
| John C ReedEVP, Innovative Medicine, R&D | Sold3 fills | 53,931 | $243.00 avg | $13.1M | Feb 17, 2026 |
| James D. SwansonEVP, CIO | Sold | 20,521 | $242.70 | $5.0M | Feb 17, 2026 |
| Vanessa BroadhurstEVP, Global Corp Affairs | Sold | 6,197 | $243.39 | $1.5M | Feb 17, 2026 |
| James D. SwansonEVP, CIO | Sold2 fills | 41,559 | $243.73 avg | $10.1M | Feb 13, 2026 |
| Joaquin DuatoCEO and Chairman of the Board, Director | Sold2 fills | 100,000 | $221.23 avg | $22.1M | Jan 26, 2026 |
| John G MorikisDirector | Bought | 1,250 | $206.15 | $258K | Nov 26, 2025 |
| & Johnson Johnson10% owner | Sold | 6,337 | $10.03 | $64K | Nov 26, 2025 |
| & Johnson Johnson10% owner | Sold | 2,200 | $10.06 | $22K | Nov 24, 2025 |
| & Johnson Johnson10% owner | Sold | 500 | $10.00 | $5,000 | Nov 21, 2025 |
| & Johnson Johnson10% owner | Sold | 1,000 | $10.00 | $10K | Nov 12, 2025 |
| & Johnson Johnson10% owner | Sold | 200 | $10.00 | $2,000 | Nov 7, 2025 |
| & Johnson Johnson10% owner | Sold | 52,332 | $10.21 | $534K | Nov 6, 2025 |
Other insider moves (63): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Timothy SchmidEVP, WW Chair, MedTech | Option exercise2 fills | 33,597 | $144.99 avg | $4.9M | Sep 2, 2026 |
| Jennifer L TaubertEVP, WWC. Innovative Medicine | Option exercise | 15,000 | $115.67 | $1.7M | Aug 17, 2026 |
| Joaquin DuatoCEO and Chairman of the Board, Director | Option exercise | 123,291 | $115.67 | $14.3M | Aug 13, 2026 |
| Elizabeth ForminardEVP, Chief Legal Officer | Option exercise | 9,344 | $131.94 | $1.2M | Aug 6, 2026 |
| Vanessa BroadhurstEVP, Global Corp Affairs | Option exercise2 fills | 23,054 | $130.77 avg | $3.0M | Jul 20, 2026 |
| Kathryn E WengelEVP, Chief TO and Risk Officer | Option exercise | 10,000 | $115.67 | $1.2M | Jun 11, 2026 |
| John C ReedEVP, Innovative Medicine, R&D | Tax withholding | 11,002 | $229.85 | $2.5M | May 1, 2026 |
| John C ReedEVP, Innovative Medicine, R&D | Option exercise | 25,255 | – | – | May 1, 2026 |
| Robert J DeckerVP Corporate Controller | Option exercise | 4,075 | $115.67 | $471K | Feb 27, 2026 |
| Timothy SchmidEVP, WW Chair, MedTech | Option exercise2 fills | 22,623 | $121.17 avg | $2.7M | Feb 18, 2026 |
| Joseph J WolkExec VP, CFO | Option exercise3 fills | 64,693 | $126.65 avg | $8.2M | Feb 17, 2026 |
| John C ReedEVP, Innovative Medicine, R&D | Option exercise2 fills | 51,648 | $156.89 avg | $8.1M | Feb 17, 2026 |
| James D. SwansonEVP, CIO | Option exercise | 20,521 | $164.62 | $3.4M | Feb 17, 2026 |
| Joaquin DuatoCEO and Chairman of the Board, Director | Tax withholding2 fills | 3,562 | $243.45 avg | $867K | Feb 15, 2026 |
| Jennifer L TaubertEVP, WWC. Innovative Medicine | Tax withholding2 fills | 1,761 | $243.45 avg | $429K | Feb 15, 2026 |
| Joseph J WolkExec VP, CFO | Tax withholding2 fills | 1,675 | $243.45 avg | $408K | Feb 15, 2026 |
| Elizabeth ForminardEVP, Chief Legal Officer | Tax withholding2 fills | 1,036 | $243.45 avg | $252K | Feb 15, 2026 |
| John C ReedEVP, Innovative Medicine, R&D | Tax withholding2 fills | 913 | $243.45 avg | $222K | Feb 15, 2026 |
| Kathryn E WengelEVP, Chief TO and Risk Officer | Tax withholding2 fills | 635 | $243.45 avg | $155K | Feb 15, 2026 |
| James D. SwansonEVP, CIO | Tax withholding2 fills | 523 | $243.45 avg | $127K | Feb 15, 2026 |
| Vanessa BroadhurstEVP, Global Corp Affairs | Tax withholding2 fills | 522 | $243.45 avg | $127K | Feb 15, 2026 |
| Timothy SchmidEVP, WW Chair, MedTech | Tax withholding2 fills | 463 | $243.45 avg | $113K | Feb 15, 2026 |
| Kristen MulhollandEVP, Chief HR Officer | Tax withholding2 fills | 423 | $243.45 avg | $103K | Feb 15, 2026 |
| Robert J DeckerVP Corporate Controller | Tax withholding2 fills | 189 | $243.45 avg | $46K | Feb 15, 2026 |
| James D. SwansonEVP, CIO | Option exercise2 fills | 1,201 | – | – | Feb 15, 2026 |
| Kathryn E WengelEVP, Chief TO and Risk Officer | Option exercise2 fills | 1,241 | – | – | Feb 15, 2026 |
| Kristen MulhollandEVP, Chief HR Officer | Option exercise2 fills | 994 | – | – | Feb 15, 2026 |
| Joseph J WolkExec VP, CFO | Option exercise2 fills | 3,849 | – | – | Feb 15, 2026 |
| Robert J DeckerVP Corporate Controller | Option exercise2 fills | 683 | – | – | Feb 15, 2026 |
| John C ReedEVP, Innovative Medicine, R&D | Option exercise2 fills | 3,196 | – | – | Feb 15, 2026 |
| Elizabeth ForminardEVP, Chief Legal Officer | Option exercise2 fills | 2,024 | – | – | Feb 15, 2026 |
| Jennifer L TaubertEVP, WWC. Innovative Medicine | Option exercise2 fills | 3,441 | – | – | Feb 15, 2026 |
| Timothy SchmidEVP, WW Chair, MedTech | Option exercise2 fills | 2,054 | – | – | Feb 15, 2026 |
| Joaquin DuatoCEO and Chairman of the Board, Director | Option exercise2 fills | 8,187 | – | – | Feb 15, 2026 |
| Vanessa BroadhurstEVP, Global Corp Affairs | Option exercise2 fills | 1,018 | – | – | Feb 15, 2026 |
| Joaquin DuatoCEO and Chairman of the Board, Director | Tax withholding2 fills | 32,668 | $244.55 avg | $8.0M | Feb 13, 2026 |
| James D. SwansonEVP, CIO | Option exercise4 fills | 51,418 | $132.73 avg | $6.8M | Feb 13, 2026 |
| Joseph J WolkExec VP, CFO | Tax withholding2 fills | 16,455 | $244.55 avg | $4.0M | Feb 13, 2026 |
| Jennifer L TaubertEVP, WWC. Innovative Medicine | Tax withholding2 fills | 13,956 | $244.55 avg | $3.4M | Feb 13, 2026 |
| Elizabeth ForminardEVP, Chief Legal Officer | Tax withholding2 fills | 7,325 | $244.55 avg | $1.8M | Feb 13, 2026 |
| Kathryn E WengelEVP, Chief TO and Risk Officer | Tax withholding2 fills | 6,631 | $244.55 avg | $1.6M | Feb 13, 2026 |
| Vanessa BroadhurstEVP, Global Corp Affairs | Tax withholding2 fills | 3,892 | $244.55 avg | $952K | Feb 13, 2026 |
| James D. SwansonEVP, CIO | Tax withholding2 fills | 3,690 | $244.55 avg | $902K | Feb 13, 2026 |
| Timothy SchmidEVP, WW Chair, MedTech | Tax withholding2 fills | 1,824 | $244.55 avg | $446K | Feb 13, 2026 |
| Kristen MulhollandEVP, Chief HR Officer | Tax withholding2 fills | 1,162 | $244.55 avg | $284K | Feb 13, 2026 |
| Robert J DeckerVP Corporate Controller | Tax withholding2 fills | 866 | $244.55 avg | $212K | Feb 13, 2026 |
| Kathryn E WengelEVP, Chief TO and Risk Officer | Option exercise2 fills | 14,357 | – | – | Feb 13, 2026 |
| Kristen MulhollandEVP, Chief HR Officer | Option exercise2 fills | 4,012 | – | – | Feb 13, 2026 |
| Joseph J WolkExec VP, CFO | Option exercise2 fills | 39,242 | – | – | Feb 13, 2026 |
| Robert J DeckerVP Corporate Controller | Option exercise2 fills | 3,053 | – | – | Feb 13, 2026 |
| Elizabeth ForminardEVP, Chief Legal Officer | Option exercise2 fills | 14,357 | – | – | Feb 13, 2026 |
| Jennifer L TaubertEVP, WWC. Innovative Medicine | Option exercise2 fills | 28,714 | – | – | Feb 13, 2026 |
| Timothy SchmidEVP, WW Chair, MedTech | Option exercise2 fills | 4,877 | – | – | Feb 13, 2026 |
| Joaquin DuatoCEO and Chairman of the Board, Director | Option exercise2 fills | 76,523 | – | – | Feb 13, 2026 |
| Vanessa BroadhurstEVP, Global Corp Affairs | Option exercise2 fills | 9,002 | – | – | Feb 13, 2026 |
| Kathryn E WengelEVP, Chief TO and Risk Officer | Tax withholding | 27,270 | $239.99 | $6.5M | Feb 6, 2026 |
| Kathryn E WengelEVP, Chief TO and Risk Officer | Option exercise | 38,945 | $101.87 | $4.0M | Feb 6, 2026 |
| Timothy SchmidEVP, WW Chair, MedTech | Tax withholding | 10,335 | $239.99 | $2.5M | Feb 6, 2026 |
| Timothy SchmidEVP, WW Chair, MedTech | Option exercise | 15,571 | $101.87 | $1.6M | Feb 6, 2026 |
| Kristen MulhollandEVP, Chief HR Officer | Tax withholding | 3,335 | $239.99 | $800K | Feb 6, 2026 |
Trades by members of Congress
21 members reported 29 buys and 33 sales since Mar 15, 2023. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Lloyd Doggett D | Bought | $1,001–$15K | Sep 8, 2026 | Oct 5, 2026 | Self |
| Thomas H. Kean, Jr. R | Sold some | $1,001–$15K | Aug 27, 2026 | Sep 12, 2026 | Self |
| Richard McCormick R | Sold | $1,001–$15K | Jul 30, 2026 | Aug 14, 2026 | Self |
| Thomas H. Kean, Jr. R | Sold some | $1,001–$15K | Jun 29, 2026 | Jul 15, 2026 | Self |
| Thomas H. Kean, Jr. R | Sold some | $1,001–$15K | Jun 2, 2026 | Jul 15, 2026 | Self |
| Lloyd Doggett D | Bought | $1,001–$15K | Jun 9, 2026 | Jul 6, 2026 | Self |
| Thomas H. Kean, Jr. R | Sold some | $1,001–$15K | Mar 26, 2026 | Apr 13, 2026 | Self |
| Richard McCormick R | Sold some | $1,001–$15K | Mar 19, 2026 | Apr 7, 2026 | Self |
| Richard McCormick R | Sold some | $1,001–$15K | Mar 19, 2026 | Apr 7, 2026 | Self |
| Lloyd Doggett D | Bought | $1,001–$15K | Mar 10, 2026 | Apr 6, 2026 | Self |
| Thomas H. Kean, Jr. R | Sold some | $15K–$50K | Jan 23, 2026 | Feb 19, 2026 | Self |
| Julie Johnson D | Sold | $1,001–$15K | Dec 18, 2025 | Jan 15, 2026 | Joint |
| Lloyd Doggett D | Bought | $1,001–$15K | Dec 9, 2025 | Jan 2, 2026 | Self |
| Thomas H. Kean, Jr. R | Sold some | $15K–$50K | Nov 20, 2025 | Dec 19, 2025 | Self |
| Julie Johnson D | Sold some | $1,001–$15K | Nov 13, 2025 | Dec 11, 2025 | Joint |
| Richard McCormick R | Bought | $1,001–$15K | Nov 5, 2025 | Dec 9, 2025 | Self |
| Jared Moskowitz D | Sold some | $1,001–$15K | Oct 10, 2025 | Nov 22, 2025 | Child |
| Jared Moskowitz D | Sold some | $1,001–$15K | Oct 10, 2025 | Nov 22, 2025 | Child |
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 31, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Val T. Hoyle D | Sold | $1,001–$15K | Sep 23, 2025 | Oct 10, 2025 | Spouse |
| Sheri Biggs R | Sold | $15K–$50K | Mar 19, 2025 | Oct 5, 2025200 days later | Spouse |
| Richard McCormick R | Bought | $1,001–$15K | Mar 15, 2023 | Sep 17, 2025917 days later | Self |
| Lisa C. McClain R | Bought | $1,001–$15K | Aug 4, 2025 | Sep 12, 2025 | Spouse |
| Val T. Hoyle D | Bought | $1,001–$15K | Oct 29, 2024 | Sep 12, 2025318 days later | Spouse |
| Kelly Morrison D | Sold some | $1,001–$15K | Aug 19, 2025 | Sep 11, 2025 | Self |
| Julie Johnson D | Sold some | $1,001–$15K | Aug 14, 2025 | Sep 11, 2025 | Joint |
| Thomas H. Kean, Jr. R | Sold some | $15K–$50K | Jul 31, 2025 | Aug 20, 2025 | Self |
| Ritchie Torres D | Bought | $1,001–$15K | Sep 26, 2024 | Aug 20, 2025328 days later | Self |
| Lisa C. McClain R | Sold | $1,001–$15K | Jun 24, 2025 | Aug 13, 202550 days later | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Jun 17, 2025 | Aug 13, 202557 days later | Spouse |
| Scott Franklin R | Sold | $15K–$50K | Jun 16, 2025 | Jul 14, 2025 | Joint |
| Lloyd Doggett D | Bought | $1,001–$15K | Jun 10, 2025 | Jul 7, 2025 | Self |
| Scott Franklin R | Bought | $1,001–$15K | Aug 7, 2024 | Jul 3, 2025330 days later | Spouse |
| Jefferson Shreve R | Sold | $50K–$100K | May 12, 2025 | Jun 22, 2025 | Self |
| Pete Sessions R | Sold | $15K–$50K | Jun 12, 2025 | Jun 21, 2025 | Spouse |
| Gilbert Ray Cisneros, Jr. D | Bought | $15K–$50K | May 30, 2025 | Jun 6, 2025 | Self |
| Josh Gottheimer D | Sold some | $1,001–$15K | Apr 9, 2025 | May 14, 2025 | Joint |
| Julie Johnson D | Sold | $1,001–$15K | Apr 1, 2025 | May 14, 2025 | Joint |
| Bruce Westerman R | Sold | $1,001–$15K | Apr 21, 2025 | May 12, 2025 | Self |
| Marjorie Taylor Greene R | Bought | $1,001–$15K | May 5, 2025 | May 6, 2025 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Apr 29, 2025 | May 6, 2025 | Self |
| Robert P. Bresnahan, Jr. R | Sold | $1,001–$15K | Apr 8, 2025 | Apr 28, 2025 | Self |
| George Whitesides D | Sold | $100K–$250K | Mar 24, 2025 | Apr 23, 2025 | Self |
| Bruce Westerman R | Bought | $1,001–$15K | Mar 3, 2025 | Apr 16, 2025 | Self |
| Jefferson Shreve R | Bought | $15K–$50K | Mar 5, 2025 | Apr 11, 2025 | Self |
| Josh Gottheimer D | Sold some | $1,001–$15K | Mar 7, 2025 | Apr 10, 2025 | Joint |
| Gilbert Ray Cisneros, Jr. D | Bought | $15K–$50K | Mar 31, 2025 | Apr 7, 2025 | Self |
| Lloyd Doggett D | Bought | $1,001–$15K | Mar 4, 2025 | Apr 7, 2025 | Self |
| Jefferson Shreve R | Bought | $15K–$50K | Feb 24, 2025 | Mar 9, 2025 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Jan 24, 2025 | Feb 11, 2025 | Self |
| Josh Gottheimer D | Bought | $1,001–$15K | Jan 24, 2025 | Feb 10, 2025 | Joint |
| Josh Gottheimer D | Bought | $1,001–$15K | Jan 21, 2025 | Feb 10, 2025 | Joint |
| Josh Gottheimer D | Bought | $1,001–$15K | Jan 16, 2025 | Feb 10, 2025 | Joint |
| Marjorie Taylor Greene R | Bought | $1,001–$15K | Jan 8, 2025 | Jan 27, 2025 | Self |
| Marjorie Taylor Greene R | Bought | $1,001–$15K | Jan 8, 2025 | Jan 27, 2025 | Self |
| Marjorie Taylor Greene R | Bought | $1,001–$15K | Jan 8, 2025 | Jan 27, 2025 | Self |
| Kevin Hern R | Sold | $100K–$250K | Dec 31, 2024 | Jan 15, 2025 | Joint |
| Josh Gottheimer D | Bought | $1,001–$15K | Dec 12, 2024 | Jan 14, 2025 | Joint |
Latest SEC filings
- Quarterly report 10-Q · Oct 21, 2026
- News filing: Quarterly results 8-K · Oct 13, 2026
- Insider plans to sell 144 · Sep 2, 2026
- Insider plans to sell 144 · Aug 17, 2026
- Insider plans to sell 144 · Aug 13, 2026
- Insider plans to sell 144 · Aug 6, 2026
- Insider plans to sell 144 · Aug 5, 2026
- News filing: Executive or board change 8-K · Aug 4, 2026
- News filing: Public announcement (Reg FD) 8-K · Jul 29, 2026
- News filing: Public announcement (Reg FD) 8-K · Jul 28, 2026
- Quarterly report 10-Q · Jul 23, 2026
- Insider plans to sell 144 · Jul 20, 2026
- News filing: Quarterly results 8-K · Jul 15, 2026
- Insider plans to sell 144 · Jun 11, 2026
- News filing: Shareholder vote results 8-K · Apr 28, 2026
- Quarterly report 10-Q · Apr 22, 2026
- News filing: Quarterly results, Other news 8-K · Apr 14, 2026
- Shareholder meeting proxy DEF 14A · Mar 11, 2026
- Insider plans to sell 144 · Feb 27, 2026
- Insider plans to sell 144 · Feb 20, 2026
- Insider plans to sell 144 · Feb 18, 2026
- Insider plans to sell 144 · Feb 17, 2026
- Insider plans to sell 144 · Feb 17, 2026
- Insider plans to sell 144 · Feb 17, 2026
- Insider plans to sell 144 · Feb 17, 2026
About Johnson & Johnson
Business description
- Industry
- Pharmaceutical Preparations
- Sector
- Life Sciences
- Headquarters
- New Brunswick, NJ
- Incorporated in
- NJ
- Fiscal year ends
- January 3
- Exchange
- NYSE
- Filer size
- Large accelerated filer
- Formerly
- JOHNSON & JOHNSON ET AL
- SEC company number (CIK)
- 200406
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.